Mindstrong Health raises USD 31 million

Mindstrong Health has increased its Series B investment round with an additional $31 million, led by General Catalyst.

The company, based in Palo Alto, California, aims to transform mental health through ‘measurement science’. Its service continuously measures cognitive function and mood, and thereby enables early intervention and support through its telehealth service with licensed practitioners.

“We are investing in Mindstrong because we think that its novel diagnostic approach and integrated healthcare delivery model can be the blueprint for a modern mental health system” said Hemant Taneja, managing director at General Catalyst.